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Aim and objectives. To provide a critical analysis of key concepts associated with Postnatal Depression (PND) to facilitate health care professionals with improving standards of care.
Background. PND is often inadequately understood by healthcare professionals. The objective was to clarify and present understandings of PND.  PND may result in referral to Community Mental Health Teams and although initial contact and management is usually through Primary Care, increasingly there is involvement of liaison mental health nurses.
Design. A literature review and synthesis of research papers on PND was conducted.
Methods. Using the key words; postnatal depression, postpartum, puerperium, perinatal, therapy, trial, review, systematic, 135 articles were yielded and limited to 57, which were critically reviewed and categorised into key concepts and themes. 
Results. Synthesis of literature in relation to PND has facilitated construction of an evidence-based contemporary picture of clinical manifestation, aetiology, methods of screening, preventing, treating and managing PND.
Conclusions. The veracity of the evidence surrounding the aetiology and treatment of PND is variable.  Interventions are often ineffective and a vacuum in the evidence base exists leaving a dynamic environment for researchers to identify more successful ways of predicting, detecting, treating and managing PND. 
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Evidence from the literature relating to post natal depression is reviewed.

The evidence is summarised with particular regard to causes, presentations, screening, prevention, treatment and management.






The postnatal period is a time when childbearing women undergo considerable psychological adjustment (Gregory et al 2000).  Although the majority of women adapt to parenthood with success (Lutz & May 2007), there are some who experience emotional distress.  The incidence of Post Natal Depression (PND) has been reported as 13-15% by O’Hara and Swain (1996), 21% by Gavin et al (2005) and 9% by Evans et al (2001), producing a range of 100-150 per 1,000 childbearing women (SIGN 2002). The World Health Organisation (WHO) estimate that depression will be the second leading cause of premature death and morbidity by 2020 (Murray & Lopez 1996). So what is PND?

PND is a non psychotic depressive illness that occurs in the first month post childbirth (American Psychiatric Association (APA) 2000).  It is defined in the Diagnostic and Statistical Manual of Mental Disorders IV Text Revision (DSM-IV-TR) as a major depressive episode that begins within one month of delivery (APA 2000).  PND is a dangerous thief that causes misery and robs women of precious time with their infant (Beck 1999).  





To answer the research question, an extensive literature review of existing academic writing about PND was carried out.  A broad literature review was performed, instead of a systematic review, because the latter is viewed as a research method of data extraction (Burns & Grove 2001) and a broad literature review is different to a systematic review in that it has the definitive goal of bringing the reader up to date on contemporary literature about the topic in question (Cooper 1998).  Four methods were used to retrieve relevant papers:

(a)	An electronic literature search of databases provided through Ovid online; Health databases included MEDLINE, CINAHL, EMBASE, PsycINFO. Evidence-based databases included The Cochrane Library, covering the Cochrane Database of systematic Reviews (CDSR) and the Cochrane Controlled Trials Register (CCTR).
(b)	A university library hand search. 
(c)	A search on the internet using google and yahoo search engines. 
(d)	A retrieval of relevant secondary references cited in the papers reviewed.











Beck (2001) meta-analysed 84 studies to determine risk factors that can predict an increased likelihood of a woman developing PND.  Thirteen aetiological predictors were identified: (1) prenatal depression, (2) low self esteem, (3) pre-existing stressful childcare, (4) prenatal anxiety, (5) lack of social support, (6) additional life stress, 




The quantity of these predictors calls into question their usefulness at forecasting impending development of PND.  In a meta-analysis of 59 studies, that included in total (n=12,810) participants, O’Hara and Swain (1996) concluded that the prevalence rate of PND based on predictors was 13%. 





It is important to assess the severity of PND before embarking on treatment and be aware that women may ascribe the label severe to what may on diagnosis in fact be moderate PND.  Screening for PND is currently carried out in most areas of the UK (Murray et al 2004), with the Edinburgh PND Scale (EPDS) (Cox et al 1987) the main screening tool used by health care professionals in the UK.  The EPDS has proven to be an effective diagnostic tool, although its sensitivity, specificity and predictive power depends on chosen cut off scores (Appleby et al 1994, Beck & Gable 2001).  Since the EPDS (Cox et al 1987) has shown a limited positive predictive value that lies between 44% - 73% (Cox et al 1987, Harris et al 1989, Muzik et al 2000), its use is recommended alongside Goldberg’s (1978) 12 item General Health Questionnaire (GHQ) (Lee et al, 2000). Lee et al (2000) found the positive predictive value of the EPDS to be 44% and the GHQ 52%, but when used in combination this quotient increased to 78%.  NICE (2007) recommend that health professionals are trained to use screening tools and interpret results.  Positive scores on the self harm item of the EPDS indicate the need to assess risk to both mother and baby.  Also upon diagnosis, an evidence based protocol should be in place to direct health care professionals towards appropriate management and treatment.  





Five studies reflected a growth of interest in preventing PND (Morrell et al 2000, Shields et al 1997, Brugha et al 2000, Elliott et al 2000, Meyer et al 1994)

Morrell et al (2000) conducted an RCT which found no mental health benefit from additional home visits by a community postnatal support worker, compared with the traditional system that involves community midwife visits. 623 postnatal women were allocated at random to an intervention (n=311) or control (n=312) group.  The intervention group received 10 three hour home visits by a community postnatal support worker in the first postnatal month.  At 6 weeks, no significant improvement in mental health status among women in the intervention group was found.  Shields et al (1997) conducted an RCT in which psychosocial outcomes were measured in a group who received midwife-managed care (MDU) (n=648), compared with a group who were given conventional postnatal care (n=651).  Women in the MDU produced healthier EPDS scores than those in the traditional care group, thus providing evidence to support “midwife led care”.  Brugha et al (2000) conducted an RCT that measured effectiveness of a “prepared for parenthood” group who received structured antenatal risk factor reducing interventions designed to increase social support and problem-solving skills.  Results were compared against a control group who received routine antenatal care, with no significant difference found between groups on measures of PND.  Brugha et al (2000) concluded that PND prevention services should not implement antenatal support programmes on these lines. That is, not until further research has demonstrated effectiveness of such methods.  Elliott et al (2000) conducted a similar RCT that measured effectiveness of a “preparation for parenthood” program at preventing/reducing PND.  EPDS scores of those “prepared for parenthood” were significantly better than results from those who received routine care.  Findings evidence an improvement in postnatal mental health from incorporating interventions such as antenatal classes and postnatal support groups into existing systems of maternity care.  Meyer et al (1994) measured the effectiveness at reducing PND scores from providing individualised family-based interventions to women with preterm infants.  Participants comprised a random sample of 34 families with preterm infants ( 1500 g).  Using the Beck Depression Inventory, the group who received the intervention reported a significant decrease in depression scores. A longitudinal study is recommended to determine whether these short-term benefits persist beyond the newborn period.





The effectiveness of prescription drugs in reducing PND measures is supported by research evidence, which is summarised below.

Prescription drugs
Antidepressants may be considered for use in women with mild, moderate or severe PND, particularly when they are unresponsive or reluctant to participate in non-drug management programs (NICE 2007).  Pharmacological treatments include use of antidepressants (Appleby et al 1997) and hormone therapies (Gregoire et al 1996).  There are 2 types of antidepressants: (1) Tricyclic Antidepressants (TCA), e.g., imipramine, nortriptyline and sertraline, and (2) Selective Serotonin Re-uptake Inhibitor’s (SSRI), e.g., fluoxetine, sertraline and citalopram. TCA’s work by blocking neuronal uptake of noradrenaline and serotonin, and SSRIs block the reabsorption of serotonin by the presynaptic neurone.

The TCA’s nortriptyline and sertraline have been positively evaluated by Logsdon et al (2003). Logsdon et al (2003) randomly assigned (n=61) moderate to severely depressed women into two groups.  One group received nortriptyline and the other sertraline. At 8 weeks, scores on depression scales, symptoms, energy levels, sexual desire and expectations of partner and self improved.

The Cochrane review by Hoffbrand et al (2001) concluded that PND is equally well treated with the SSRI fluoxetine and Cognitive Behavioural Counselling (CBC). Appleby et al (1997) compared the effects of fluoxetine against a placebo in a double blind RCT that consisted of three groups: (1) fluoxetine, (2) placebo plus one CBC session, (3) placebo plus 6 CBC sessions. Participants included 87 depressed women 6-8 weeks post childbirth. Mental health status was measured at 1, 4, and 12 weeks using the EPD scale and Hamilton Depression Scale.  Depression scores of participants receiving fluoxetine was significantly improved over the other two groups. There was also a significant improvement from having 6 sessions of CBC in comparison to one.  Results support that both fluoxetine and CBC are effective treatments for non-psychotic PND.  Given that both treatments work, choice of treatment should be made by the women herself (Appleby et al 1997).

Kirsch et al (2008) meta-analysed clinical trials that assessed effectiveness of 6 SSRIs between the years of 1987-1999.  All 6 drugs, to include fluoxetine and sertraline, were found to significantly improve depression scores, compared with a placebo group.  These improvements increased dependent on severity of depression at commencement of treatment. Due to reduced side-effects in comparison to TCA’s, SSRI’s remain the main group of drugs prescribed to treat PND (Looper 2007). 

The tricyclics imipramine, nortriptyline and sertraline present at relatively low levels in breast milk, whilst the SSRI’s citalopram and fluoxetine (​http:​/​​/​www.patient.co.uk​/​DisplayConcepts.asp?WordId=FLUOXETINE&MaxResults=50​) present at relatively high levels (NICE 2007). One advantage of SSRI’s, is that they are better tolerated and less toxic in overdose than TCA’s. NICE (2007) do not recommend any particular drug, since there are no conclusive RCT’s to support singular cost and benefit analysis of each drug. 

Hormones
Dropping oestrogen/progesterone levels post delivery are often attributed responsibility for causing PND (Nott et al 1976), with this the main rationale for implementing hormone treatment (Dennis et al 1999). The Cochrane review of oestrogens and progestins for inhibiting and remedying PND (Dennis et al 1999) includes one perinatal trial by Lawrie et al (1998), which reported a significant negative effect on PND scores. As a consequence, progestogen use (e.g., norethisterone) to prevent PND is contraindicated. It is also recommended that use of progestogens as contraception should be re-examined. In an RCT, Gregoire et al (1996) demonstrated that transdermal oestrogen was more successful than a placebo for treating moderate to severe PND. The Gregoire et al (1996) study may be flawed, since half of the participating women in the treatment group were concurrently taking antidepressants. 

Evidence supports that there is no place for synthetic progestogens in treatment of PND (NICE 2007). In fact, long-acting norethisterone (​http:​/​​/​www.patient.co.uk​/​DisplayConcepts.asp?WordId=NORETHISTERONE&MaxResults=50​) may increase the risk of developing PND (NICE 2007). Moreover, progesterone-only contraceptives (​http:​/​​/​www.patient.co.uk​/​DisplayConcepts.asp?WordId=CONTRACEPTIVES&MaxResults=50​) should be used with caution in the postnatal period, particularly in women with a history of depression before or during pregnancy (NICE 2007). Oestrogen therapy may be of modest value in the latter stages of severe PND (NICE 2007). 

Psychosocial therapy
Talking therapies such as Non Directive Counselling (NDC) and Cognitive Behavioural Therapy (CBT), without concurrent use of antidepressants, are both methods of treating PND. NICE (2007) recommends 4-6 sessions of CBT or interpersonal psychotherapy for pregnant women with symptoms of depression and/or anxiety who do not meet diagnostic criteria, but symptoms interfere with social functioning. 

Dennis and Hodnett (2007) conducted a meta-analysis which reported that, although methodological quality of trials was not strong, results support that psychosocial interventions can be effective at treating PND. 

Holden et al (1989) conducted an RCT to determine whether counselling by health visitors is helpful in management of PND.  Sixty women diagnosed 6 weeks post partum, received 8 weekly counselling visits by trained health visitors.  Self report scales and psychiatric interviews were implemented to identify depression before and after the intervention. At 3 months, 18 (69%) of the 26 women in the treatment group, and 9 (38%) of the 24 women in the control group had fully recovered.  This evidence supports that counselling by trained health visitors is a valuable method of treating non-psychotic PND.

Wickberg and Hwang (1996) found similar results in a two-stage screening procedure. They issued the EPDS at 8 and 12 weeks postpartum, along with the Montgomery-Åsberg Depression Rating Scale (MADRS) and DSM-III-R at 13 weeks. Forty one depressed women were randomly allocated to a group who received counselling or a control who received routine care. Six weekly counselling sessions were carried out by a Child Health Clinic nurse.  Twelve (80%) of 15 women in the intervention group fully recovered, compared to 4 (25%) of 16 in the control group. Consequently, counselling by trained nurses in Sweden attested as helpful for treating PND.

Murray et al (2003) evaluated the effects of 3 psychological treatments for PND and measured their effects on the mother/child relationship.  Women with PND (n=193) were randomly assigned to 3 groups who recieved: (1) routine primary care, (2) non-directive counselling, or (3) CBT or psychodynamic therapy.  Participants were assessed at 4, 18 and 60 months post-partum.   All 3 treatments had a significant benefit on maternal reports of quality of relationship with their infants.  Counselling improved infant emotion and behaviour ratings at 18 months, with more sensitive early mother/infant interactions found.  Early intervention was only of short-term benefit.  

O’Hara et al (2000) report success of therapy at halting PND.  120 postpartum women who met the DSM-IV-TR (APA 2000) criteria for major PND were randomly assigned to a group who received 12 weeks of interpersonal psychotherapy or a control.  The psychotherapy group had a significant reduction in symptoms of PND and an improvement in social adjustment compared to the control.  Hence, psychotherapy may be an effective alternative to pharmacological treatment, particularly in breast feeding women. 

Cooper et al (2003) conducted a longitudinal RCT that compared 3 groups who received different forms of psychotherapy against a control who received routine care.  Between therapies, no difference in effectiveness at reducing PND was found.  All 3 made a substantial difference to PND scores compared to the control. 

In relation to options of management, evidence supporting one psychological therapy over another is small. Consequently, choice of therapy should be based on patient suitability, preference and availability (NICE 2007). Health care professionals are advised by NICE (2007) to:
-	Observe patients with mild depression who do not want any intervention (re-assessment must occur within 2 weeks). 
-	Offer self-help programmes based on CBT or exercise.
-	Provide non-directive counseling (​http:​/​​/​www.patient.co.uk​/​DisplayConcepts.asp?WordId=COUNSELLING&MaxResults=50​) (listening visits) to the woman’s home.
-	Offer brief CBT or interpersonal psychotherapy. 

Partner involvement
Misri et al (2000) determined the impact of a supportive partner on PND scores. Participants received a comprehensive psychiatric assessment and were enrolled in the study if they met the DSM-IV criteria for major PND. Group 1 (control) consisted of women only (n=13) and group 2 (support group) consisted of women and their partners (n=16).  Both groups were seen for 7 psychoeducational visits. Partners participated in 4 of these 7 visits.  Measuring scales included the EPDS, Kellner Symptom Questionnaire, Dyadic Adjustment Scale (DAS) and the Parental Bonding Instrument (PBI).  Relative to the control, support-group patients displayed a significant decrease in symptoms of PND, with partner support further promoting improvement.

Omega-3 fatty acids
Freeman et al (2006) conducted an RCT to measure effectiveness of omega-3 fatty acids as a treatment for PND.  Participants were randomized to 0.5 g/day (n = 6), 1.4 g/day (n = 3), or 2.8 g/day (n = 7) over 8 weeks.  Using the EPDS and Hamilton Rating Scale, scores pre and post-test did not differ.  This study is limited by small sample size and lack of a placebo group.  Consequently, omega-3 fatty acids have not been shown to improve PND scores. 

St Johns Wort
There is insufficient evidence to support use of St. John’s Wort as a successful treatment for PND.  No complementary treatment is as/more effective for treating PND than conventional medicines or psychological counselling (SIGN, 2002).  Clinical guidelines recommend that St. John’s Wort, or any other alternative medicines, should not be used during pregnancy or lactation (SIGN 2002).

Physical Exercise
Currie and Develin (2002) surveyed (n=450) women and found that 87% believed that pram walking reduced symptoms of PND.  Armstrong and Edwards (2004) carried out a systematic review and meta-analysis of RCT’s that measured effectiveness of exercise and its effects upon symptoms of PND.  Compared with the no exercise groups, activity improved PND scores.  Since results were taken from 5 small trials, further research is recommended. 





NICE (2007) has released evidence-based guidance for appropriate management of PND during the ante/postnatal period.  NICE recommends that health care professionals ask childbearing women the following questions (NICE 2007) (see Table 3): 
Table 3 here
Measuring tools such as the EPDS or HADS are available for use to clinch a suspected diagnosis of PND.  They may also be used to gauge success of treatment.  Once PND has been diagnosed and the extent established, NICE (2007) recommend the “Stepped Care Approach” (see Table 4). 
                                                Table 4 here








Much of the evidence in this review is based on randomised controlled trials (RCT) and although commonly regarded as the ‘gold standard’ in treatment outcome research NICE (2007) do caution of limitations in relation to psychological approaches.  This is because post natal depression is not tightly defined and psychosocial therapies are hard to deliver uniformly and in a blinded protocol.  Women included in RCTs may not be clinically representative as those with unstable or severe illness may be excluded.  The practice implications briefly outlined in each section, however, are resonant with the Scottish Intercollegiate Guidelines Network recommendations (SIGN) (2002).  Routine assessment of mood may lead to risk management protocols to ameliorate threat of serious harm to mother and baby.  Antidepressant medicine is well evidenced when depression is moderate/severe and the NICE (2007) Stepped Care Approach provides a useful protocol enabling a structured effective approach to intervention and referral.  Talking therapies delivered by trained health workers either counselling or cognitive behavioural in nature are beneficial compared to routine care and may be combined with pharmacological treatment.  There is a clear need for public health care practitioners as well as mental health workers to develop competence in non-directive counselling and brief CBT.  The evidence supporting one antidepressant over another is small and the picture is similar for psychological therapies.  As far as possible, however, interventions should be individualised and family based.  Physical exercise is valued by mothers in reducing PND and is an area worthy of further investigation.  
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Table 1. Symptoms of PND (NICE 2007)
___________________________________
(1)	Low mood and loss of enjoyment 
(2)	Anxiety 
(3)	Disturbed sleep and eating patterns 
(4)	Poor concentration 
(5)	Low self-esteem 
(6)	Low energy levels 
(7)	Loss of libido 

Table 2. Summary of predictors of increased likelihood of a postnatal woman developing PND 

 Predictors		                                       Researchers
___________________________________________________________________________________
(1) Low social class		                         Beck (2001; O’Hara & Swain (1996); Seguin et al 
                                                                                   (1999)
___________________________________________________________________________________
(2) Life stressors during pregnancy		           O’Hara & Swain (1996); Richards (1990)  
___________________________________________________________________________________
(3) Complicated pregnancy/birth		           De Meir et al (2000); Hannah et al (1992); 
                                                                                   Johnstone et al (2001); O’Hara & Swain (1996)
___________________________________________________________________________________
(4) Difficult relationship with partner	           Beck (2001); Henshaw et al 2004; O’Hara & Swain 
      and/or family                                                       (1996); Richards (1990), Seguin et al (1999)
  __________________________________________________________________________________
(5) Lack of support, e.g., family, friends                   Beck (2001); Bloch et al 2006; O’Hara & Swain 
      marital status                                                       (1996) Richards (1990), Seguin et al (1999)
___________________________________________________________________________________
(6) History of psychopathology, e.g., depression,     Beck (2001); Bloch et al 2006; O’Hara & Swain 
      low self esteem, prenatal anxiety, baby blues     (1996)
___________________________________________________________________________________
(7) Chronic stressors, e.g., childcare,                        Beck (2001); Mandl et al (1999); O’Hara & Swain 
      problems with baby, infant temperament           (1996); Seguin et al (1999); O’Brien et al (2004)
___________________________________________________________________________________
(8) Unemployment/instability	                         Murray et al (1995); Warner et al (1996)
___________________________________________________________________________________
(9) Unplanned pregnancy			           Beck (2001); Warner et al (1996)
___________________________________________________________________________________
(10) Ambivalence over becoming a parent	           Beck (2001)
___________________________________________________________________________________
(10) Poor relationship with own mother	           Murray et al (1995)
___________________________________________________________________________________
(11) History of sexual abuse		           Benedict et al (1999)
___________________________________________________________________________________
(12) Lack of a confidente			           Richards (1990)  
___________________________________________________________________________________
(13) Bottle feeding			           Hannah et al (1992)


Table 3. Questions to be asked by health care professionals to assess childbearing women’s 




(1) Their history of mental illness, e.g., schizophrenia, bipolar disorder, depression.
(2) Any previous record of treatment by the mental health team.
(3) Family history of PND. 

At subsequent ante/post-natal checks:

(5) During the past month, have you been feeling down, depressed or hopeless? 
(6) During the past month, have you had less than usual interest or pleasure in doing 
      	      things? 

If the woman answers “yes” to questions (5) and (6) a further question should be asked:

(7) Is this something you feel you need or want help with? 


Table 4. The 'Stepped Care Approach' recommended by NICE (2007)
___________________________________________________________________________________
Step 1 - Assessment                           - Recognition.

Step 2 - Mild depression                    - Watchful waiting, guided self-help, computerised CBT, exercise, 
                                                              brief psychological interventions.

Step 3 - Moderate/severe depression - Medication, psychological interventions, social support

Step 4 - Treatment-resistant               - Medication, complex psychological interventions, combined
               psychotic or at risk                 treatments. Requires mental health specialists. Out with domain 
                                                              of primary care. 

Step 5 - Severe health neglect            - Admitted to a psychiatric unit and treated with medication,
              suicide attempt                        therapies and possibly ECT.  
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